Insights on the Global Surgical Robotic System Market Growth Predictions at a CAGR of 11.50% by 2028, DelveInsight Analysis | Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, CMR Surgical Ltd., Medicaroid Corporatio

As per DelveInsight's assessment, the Surgical Robotic System Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Surgical Robotic System have been used, which is expected to drive the demand for Surgical Robotic System in the upcoming years.

DelveInsight's "Surgical Robotic System Market" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Surgical Robotic System companies actively working in the market.

Surgical Robotic System Overview
https://www.delveinsight.com/sample-request/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Surgical robotic systems, also called robot-assisted surgical devices, are computer-assisted medical technologies that are used for pre-operative planning, surgical navigation, and minimally invasive surgical procedure execution.

Surgical Robotic System Market Insights
A number of factors, including the aging population, which is largely at-risk for conditions like prostate cancer, valvular diseases, and endometriosis, are driving up demand for surgical robotic systems. Additionally, the growing trend toward minimally invasive surgery is driving up demand for robot-assisted surgery systems, and product development innovation is paving the way for the development of smaller surgical robots, which will ultimately contribute to the overall growth of the Surgical Robotic Systems market over the 2023-2028 forecast period.

DelveInsight Analysis: The Global Surgical Robotic System market size is anticipated to reach ~USD 9.64 billion by 2028 with a growing CAGR of 11.50% during the forecasted period (2023-2028).

To know more about why North America is leading the market growth in the Surgical Robotic System market, get a snapshot of the report Surgical Robotic System Market Trends
https://www.delveinsight.com/report-store/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Surgical Robotic System Market Report
• In November 2021, Brain Navi Biotechnology, a Taiwan-based company received the CE (Conformité Européenne) Mark for their NaoTrac, a robotic-assisted surgical robot.
• In October 2021, Medtronic received the CE (Conformité Européenne) Mark for their Hugo™ robotic-assisted surgery (RAS) system thereby enabling Medtronic to access European market for this device. The device received the approval for gynecologic and urological procedures.
• In March 2021, an Israel-based company Memic Innovative Surgery received the regulatory approval from the US Food and Drug Administration for their robotically-assisted surgical device, making it the first FDA-approved surgical robotic devices for transvaginal hysterectomy.

To read more about the latest highlights related to Surgical Robotic System, get a snapshot of the key highlights entailed in the Surgical Robotic System Market Forecast Report
https://www.delveinsight.com/sample-request/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key Players in the Surgical Robotic System Market
Some of the key market players operating in the Surgical Robotic System market include- Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, avateramedical GmbH, CMR Surgical Ltd., Medicaroid Corporation, Medrobotics Corp, Asensus Surgical US, Inc, Globus Medical, Microport Scientific Corporation, Smith & Nephew PLC., Accuray Incorporated, THINK Surgical., Renishaw plc, Zimmer Biomet, Corindus, Inc (Siemens Healthineers), Preceyes BV., MicroSure, Memic Innovative Surgery Ltd and others.

COVID-19 Impact Analysis on the Surgical Robotic System Market
From 2023 to 2028, North America is anticipated to hold a dominant position in the global surgical robotic systems market. The North American Surgical Robotic Systems market is anticipated to grow positively due to the importance of key growth factors like the rising incidence of cancer, the rising incidence of degenerative bone disorders, and the rising government initiatives regarding disease treatment awareness. Additionally, the region's market expansion was aided by a high level of awareness, new product approvals, advanced healthcare infrastructure, and disposable income.
Additionally, The market for surgical robotic systems had a brief downturn when lockdown regulations were implemented in an effort to stop the spread of COVID-19 infections. Global supply chains and production processes were disrupted, which was one of the main effects of lockdowns. Apart from the previously indicated factor, there was a notable decline in the demand for products as a result of the prioritizing of the patient load related to the COVID-19 infection, which led to a considerable reduction in medical procedures. So, during the projected period, the market for Surgical Robotic System is anticipated to continue expanding (2023-2028).

Scope of the Surgical Robotic System Market Report
• Coverage: Global
• Study Period: 2020-2028
• Surgical Robotic System Market Segmentation By Application: Urology, Gynecology, Neurosurgery, Orthopedics, and Others
• Surgical Robotic System Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, and Others
• Surgical Robotic System Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Surgical Robotic System Companies: Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, avateramedical GmbH, CMR Surgical Ltd., Medicaroid Corporation, Medrobotics Corp, Asensus Surgical US, Inc, Globus Medical, Microport Scientific Corporation, Smith & Nephew PLC., Accuray Incorporated, THINK Surgical., Renishaw plc, Zimmer Biomet, Corindus, Inc (Siemens Healthineers), Preceyes BV., MicroSure, Memic Innovative Surgery Ltd and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the Surgical Robotic System market are set to emerge as the trendsetter explore @ Surgical Robotic System Manufacturer
https://www.delveinsight.com/sample-request/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Surgical Robotic System Market Report Introduction
2 Surgical Robotic System Market Executive summary
3 Regulatory and Patent Analysis
4 Surgical Robotic System Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Surgical Robotic System Market
7 Surgical Robotic System Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Surgical Robotic System Market Drivers
11. Surgical Robotic System Market Barriers
12. Project Approach
13. About DelveInsight

Interested in knowing how the Surgical Robotic System market will grow by 2028? Click to get a snapshot of the Surgical Robotic System Market Analysis
https://www.delveinsight.com/sample-request/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Latest Reports Offered By DelveInsight:

Oncology Drugs Market
https://www.delveinsight.com/report-store/oncology-drugs-market
Oncology Drugs Market By Therapy Type (Chemotherapy, Hormonal Therapy, Targeted Therapy [Gene Therapy And Immunotherapy], And Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancers, And Others), By End User (Hospitals, Specialty Clinics, And Others), and by geography is estimated to grow at a healthy CAGR forecast till 2028 due to rising prevalence of various cancers such as lung and breast cancers and growing demand for targeted therapies for cancer treatment.

Biologics Market
https://www.delveinsight.com/report-store/biologics-market
Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseases, And Others), By Manufacturing Type (In-House And Outsourced), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to rising prevalence of autoimmune disorders such as rheumatoid arthiritis and genetic disorders.

Biosimilar Market
https://www.delveinsight.com/report-store/biosimilars-market
Biosimilars Market By Product Class (Monoclonal Antibodies, Recombinant Hormone/Proteins, Anti-Inflammatory Agents, Immunomodulators, And Others), By Manufacturing Type (In-House And Outsourced/Contract), By Application (Autoimmune Diseases, Blood Disorders, Oncology, Infectious Diseases, And Others), by geography, is projected to expand at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders such as autoimmune disorders, cancers, among others and increasing demand for biosimilar drugs owing to their cost-effectiveness.

Cancer Immunotherapy Market
https://www.delveinsight.com/report-store/cancer-immunotherapy-market
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines, Checkpoint Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By End-User (Hospitals And Clinics, Specialty Centers, And Others), and by geography is expected to rise at a significant CAGR forecast till 2027 owing to the accelerating prevalence of cancers and surging healthcare expenditure across the globe

Companion Diagnostics Market
https://www.delveinsight.com/report-store/companion-diagnostics-market
Companion Diagnostics Market By Type (Product [Assays, Kits & Reagents And Instruments], and Services), Technology (Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, and Others), End-User (Hospitals, Diagnostic Labs, and Others), and Geography is expected to grow at a noteworthy CAGR till 2028 owing to the increase in the cancer burden across the globe and the growing focus on personalized medicines.

Contact Us
Gaurav Bora
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/medical-devices

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.